<DOC>
	<DOCNO>NCT03031925</DOCNO>
	<brief_summary>There substantial clinical biological intra inter-patient variability SLE . Vascular , renal neurologic deficiency organ-threatening even life-threatening , lead increase morbidity mortality . Thus , biomarkers disease activity prognosis require regular follow-up SLE patient . Implication Toll-like Receptors ( TLRs ) SLE extensively study mice model human . Self nuclear antigen bind TLRs locate surface dendritic cell , B-cells , endothelial cell , lead production pro-inflammatory cytokine pathologic autoantibody involve organ dysfunction SLE patient . Moreover , TLR expression SLE significantly higher significantly correlate disease activity . Annexin A2 ( ANXA2 ) member annexins superfamily exist monomer heterotetramer implicate several biological process . Most notably , bind ẞ2GP1/anti-ẞ2GP1 antibody mediate endothelial cell activation via TLR4 signal pathway , highlight key role Antiphospholipid Syndrome ( APS ) frequently associate SLE . ANXA2 also involve physiopathology SLE . Anti-DNA autoantibody bind ANXA2 express mesangial cell lupus nephritis . Besides , french study carry Amiens ' University Hospital show vascular lesion lupus nephritis associate significant increase vascular expression ANXA2 .</brief_summary>
	<brief_title>Detection Annexin A2 Systemic Lupus Erythematosus</brief_title>
	<detailed_description />
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<mesh_term>Nephritis</mesh_term>
	<mesh_term>Lupus Nephritis</mesh_term>
	<criteria>Inclusion criterion patient : Age ≥ 18 year old All SLE patient fulfil 1997 ACR criterion , follow Departments Internal Medicine Nephrology CHU AmiensPicardie , regardless clinical status , treatment , disease activity . Written inform consent Inclusion criterion control subject : Age ≥ 18 year old Written inform consent The patient compare age sexmatched control subject . druginduced lupus erythematosus refusal incapacity provide write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Annexin A2</keyword>
	<keyword>biomarker</keyword>
</DOC>